Events
Date 04 Feb 2026
Time 5:00 pm - 6:00 pm (HKT)
Venue Lecture Theatre T3, Meng Wah Complex
Speaker Dr. Haoxin LI
Institution The Scripps Research Institute
Self Photos / Files - 20260204_Dr. Haoxin LI Seminar Poster
 
Title:
From Chemical Genetics to Molecular Clamps: Covalent Strategies for Biological Discovery 
 
Schedule:
Date: 4th February, 2026 (Wednesday)
Time: 5 - 6 pm (HKT)
 
Venue: Lecture Theatre T3, Meng Wah Complex
 
Speaker:

Dr. Haoxin LI

 
The Scripps Research Institute
 
Biography:
Haoxin Li is a Damon Runyon and NCI K99/R00 Postdoctoral Fellow in the laboratory of Benjamin Cravatt at the Scripps Research Institute. He completed his PhD research with Stuart Schreiber at Harvard University, where he studied lipid metabolism and ferroptosis. As a postdoctoral fellow, Haoxin has integrated covalent chemistry, chemical proteomics, and genome editing to functionally annotate the ligandable proteome. Building on these platforms, he has developed a first-in-class covalent “molecular clamp” targeting an allosteric cysteine of the RNA exonuclease TOE1, which stabilizes TOE1–spliceosome interactions, drives tunable over-trimming of snRNA 3' ends, and enables chemical control of spliceosome functions. For his future independent research, his group will develop chemical biology tools to map, perturb, and drug protein and RNA complexes.
 
Abstract:

Covalent chemistry represents an attractive strategy for expanding the ligandability of the proteome, and chemical proteomics has revealed numerous electrophile-reactive cysteines residing at cryptic, non-orthosteric pockets on diverse human proteins. Determining which of these covalent binding events impact protein function, however, remains challenging. In this seminar, I will first describe a base-editing strategy to infer the functionality of cysteines by quantifying the impact of their missense mutation on cancer cell proliferation. Building on this strategy and chemical proteomics, I will then highlight our discovery of a potent and selective covalent probe HL-1B that targets an allosteric cysteine in the RNA exonuclease TOE1. I will show that this compound functions as a “molecular clamp” to stabilize TOE1 interactions with the spliceosome, trigger over-trimming of snRNAs, rewire splicing and synthetic-lethal vulnerabilities in cancer cells. Together, these studies establish a framework for developing covalent probes against cancer dependencies and for modulating protein–RNA interactions in cells, enabling precise chemical perturbation of fundamental biological processes and the development of next-generation of therapeutics.

 
- - ALL ARE WELCOME - -